During the past decade, CB Flock Research Corporation conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CB Flock Research Corporation" are "Cardiovascular Disease" (2 trials), "Dilated Cardiomyopathy" (1 trials) and "Lamin A/C Gene Mutation" (1 trials). Many other conditions were trialed in "CB Flock Research Corporation" in a lesser frequency.

Most popular intervention types in "CB Flock Research Corporation" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials) and "ARRY-371797 (PF-07265803)" (1 trials). Other intervention names were less common.

The vast majority of trials in "CB Flock Research Corporation" are 3 trials for "All" genders.

Currently, there are NaN active trials in "CB Flock Research Corporation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in CB Flock Research Corporation, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CB Flock Research Corporation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".